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ABSTRACT 
Different toxic pharmaceutical compounds can affect the efficiency of the Biological 
wastewater treatment plant. Inorder to increase the efficiency of the treatment plant, it is 
very important to screen these pharmaceuticals for their toxicity towards the activated 
sludge. Activated sludge is the main component of Biological wastewater treatment 
system. Therefore, in this work, 50 pharmaceuticals have been tested for their toxicity to 
the activated sludge. This Masteral Thesis work was done with the support of a 
pharmaceutical company called Universal Corporation. Pharmaceuticals have been 
obtained from this Corporation which is located in Nairobi, Kenya. Pharmaceutical 
industry manufactures many drugs like anti-HIV, anti- malarial, anti-inflammatory, lipid 
regulators, antibiotics, contraceptives, beta blockers and tranquilizers whose level 
should be minimum or they should be absent in the treated effluents from the treatment 
plant. OUR (Oxygen Uptake Rate) method has been used in this process for detecting 
the toxicity of these chemicals. This is the major  principle of this method for the 
measurement of toxicity of chemicals. The laboratory work was done in the Tampere 
University of Technology. For this work, OUR (Oxygen Uptake Rate) measurement 
technique is applied for the toxicity test.The activated sludge was obtained from the 
Tampere. Oxygen meter WTW Multiline P4 with Oxygen probe CellOx325 device was 
used to measure the oxygen consumption rate of the activated sludge. The graphs were 
plotted for all the measurements and the MLSS and MLVSS values were also 
calculated. In the end, inhibition percentage was calculated for all the tests and EC50 
concentration was calculated for the toxic pharmaceuticals. Out of 50 most popular 
pharmaceuticals, 11 pharmcaeuticals showed the significant inhibition percentage to the 
activated sludge. Aspirin, Cetrimide, Cetrizine, Chlorpheniramine Maleate, Caffeine 
Anhydrous, Ephedrine Hcl, Levamisole Hcl, Quinine Dihydrochloride, Diclofenac 
Sodium and Camphor were found toxic. The EC50 value for Diclofenace Sodium was 
found 23.7 mg/l. These drugs, due to its toxicity affect the efficiency of the WWTP. 
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INTRODUCTION 
The major sources of wastewater are human sewage and industrial effluents. Untreated 
wastewater, if discharged directly to the receiving water bodies in the environment can 
causes water borne diseases. So the biological waste water treatment method was 
established in the early years of twentieth century. Biological wastewater treatment 
method has been applied worldwide these days. It involves the high concentration of 
bacteria in the tanks and they remove small organic carbon molecules by eating them. 
Consequently, as the bacteria grow more, the water will be cleansed and the treated 
water is generally discharged to receiving water bodies such as river or the sea.  
Different chemicals which are toxic can produce a toxic shock that kills the bacteria in 
the wastewater treatment plant. As a result, plant may pass untreated effluent directly to 
the environment. [1] 
Presence of pharmaceuticals in wastewater treatment plant and the environment 
have caught attention during the last decade. A wide variety of pharmaceuticals ( e.g. 
anti- inflammatory drugs, lipid regulators, antibiotics, contraceptives, beta blockers and 
tranquilizers) have been detected in the different water samples like river water, ground 
water, wastewater and drinking water [2]. Drugs that are prescribed in the hospitals and 
pharmacies are excreted in the faces and urine are transferred to sewage. These drugs 
which are untreated in water treatment remain in the discharged water. There is an 
increase concern about the influence of these drugs on aquatic organisms and humans 
because of the formation of tolerance different pathogenic bacteria to anti-microbial 
drugs. Inhibition of oxygen uptake rate (OUR) by 50 % is calculated to know the 
concentration of the toxic chemical substances. An activated sludge is used in this test 
to know the effect of chemicals on it. Analyzing factors affecting the elimination of 
pharmaceuticals by activated sludge method is very important in the wastewater 
treatment. [3] 
This thesis consists of literature review and experimental part. The aim of the 
literature review is to find out what are the major inhibitory compounds in the effluent 
that reduces the efficiency of biological wastewater treatment system. This gives more 
information on what are the major group of toxic chemicals, comparison of the toxicity 
of different chemicals and the calculation of the EC50% of each chemical that proved to 
be toxic. Literature review further describes the outline of waste water treatment system, 
different methods of toxicity tests, application of oxygen uptake rate (OUR) test. The 
main aim of the thesis is to determine the inhibitory concentration of the toxic 
pharmaceuticals towards the activated sludge (AS). Uptake of oxygen by 
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microorganisms in the activated sludge is determined in the unit values. Toxic 
chemicals decrease the oxygen consumption rate by the microorganism and chemicals 
that helps in the increase in uptake rate can said to be as substrate for the 
microorganism. The obtained inhibitory concentration of the chemicals are compared 
with the standard values of most toxic chemicals such as EC50 values of 3, 5. 
Dichlorophenol, Diclofenac, Carbamazepine etc. There were already many researches 
done in the field of toxicity tests. This thesis is limited to the detection of the inhibitory 
concentration of the chemicals with the help of Oxygen Uptake Rate of the 
microorganism using activated sludge following standard Oxygen Uptake Rate 
procedure. Detecting and removing the most toxic chemicals in the biological 
wastewater treated effluent is the main purpose of this study. 
A useful tool applied in this work for measuring the toxicity of the 
pharmaceuticals is a respirometric method called Oxygen Uptake Rate (OUR). An 
activated sludge was sampled at the treatment plant in Tampere and it was transported 
to the laboratory. It was then put for aeration throughout the using period. This aeration 
helps to degrade any organic matter formed due to hydrolysis in the sludge during 
transportation. It also helps to make the sludge homogenous by breaking down the 
bulky portions of the sludge. The Mixed Liquor Suspended Solids (MLSS) and Mixed 
Liquor Volatile Suspended Solids (MLVSS) were measured in order to see the mass of 
the suspended and volatile solids. Nutrient Solution was added continuously in each 
batch of the test. The test was run with Nutrient blank, chemical blank, sludge controls 
and the sludge mixed with the pharmaceuticals. For each step, DO (Dissolved Oxygen) 
was measured with oxygen probe for 10 minutes. Different concentrations of the 
chemical were tested and compared with sludge controls inorder to see the oxygen 
uptake rate of the sludge. With the help of these DO measurements, the specific oxygen 
uptake rates were measured and compared to find out if the chemical is inhibitory. 
 
Background 
The aim of this work is to detect the toxicity of the active pharmaceuticals in the 
treatment plant. The active pharmaceuticals are the samples that are going to be used to 
detect the toxicity to the activated sludge. The samples are obtained from the Universal 
Corporation Ltd (UCL), which is a pharmaceutical company located in the industrial 
area of Nairobi, Kenya. The activated sludge was obtained from the Tampere 
Wastewater treatment plant. Oxygen Uptake Rate (OUR) method is used for measuring 
the toxicity of the pharmaceuticals in the effluent. 50 different chemicals will be tested 
for its toxicity. Effective concentration 50% will be calculated for each toxic compound. 
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2. Literature review 
2.1. Wastewater treatment and its 
component 
The main aim of wastewater treatment is to remove pollutants which can harm the 
aquatic environment after it is discharged into it. Many oxygen demanding pollutants 
are organic compounds. During wastewater treatment, there are different unit operations 
which form a process train and they are divided depending upon fundamental 
mechanisms. These mechanisms include physical, chemical and biochemical basis. 
Physical operations include such as sedimentation which is based on the idea of physics. 
Chemical law defined precipitation process. Biochemical processes include living 
microorganisms which destroy or transform chemicals through enzymatically catalyzed 
reactions [4]. Increasing discharge has pressurized for the process optimization and 
control of the wastewater treatment plant performance .There are different methods of 
evaluation and regulation of the process performance in which OUR (oxygen uptake 
rate) is a useful tool. Organic material in wastewater is removed for reducing oxygen 
consuming substances in the recipient. This process is performed by bacteria as 
wastewater treatment plant (WWTP). The biomass in activated sludge consists of 
different types of bacteria. The heterotrophic bacteria in combined with other 
microorganisms are responsible for the degradation of main organic material. [5]  
Wastewater treatment can be divided into three main stages. The removal of 
insoluble matters like grit, grease and scum from water by screening and sedimentation 
is called primary treatment of wastewater. Secondary wastewater treatment is applied to 
removal of soluble organic matters which are oxygen demanding, mostly by the action 
of microorganisms i.e. bacteria. Further removal of suspended solids and dissolved 
organic or inorganic material in the effluent from secondary wastewater treatment is 
called tertiary wastewater treatment [6]. 
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Figure 2.1. Wastewater treatment process by activated sludge method. [7] 
In figure 2.1, primary and secondary treatment of raw sewage is shown with 
different stages in different compartments. Starting from screening till purification, 
different processes are shown in which formation of primary sludge, sludge treatment 
and disposal, activated sludge processes are shown. Early wastewater treatment systems 
were designed to remove organic matter. They are designed sometimes to oxidize 
ammonia nitrogen to nitrate nitrogen. This has been the main aim for many wastewater 
treatment systems these days. Engineers are more concerned about the design of 
wastewater treatment system in order to construct efficient and cost effective plants. 
Pollutants in wastewater can be classified as soluble or insoluble on the basis of 
physical characteristics, biodegradable or non-biodegradable on the basis of 
susceptibility to alternation by microorganisms. It can be further classified as organic or 
inorganic on the basis of chemical properties, biogenic or anthropogenic on the basis of 
their origin and toxic or non-toxic on the basis of their toxicity. So the main purpose of 
any wastewater system is to remove those materials in an efficient and economical 
manner. [4] 
Different biochemical operations are included in the wastewater system plant. 
One of the major uses of biochemical operation is the treatment of sludge. Primary 
sludge results from the sedimentation of the wastewater and secondary sludge is 
produced by biomass growth in the biochemical operation. Different biochemical 
operations are shown in the below typical process flow diagram Figure 2.2. 
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Figure 2.2.Typical process of flow diagram for a wastewater treatment system illustrating the role of the biochemical 
operations. SOM- soluble organic matter, IOM- insoluble organic matter, SIM- soluble inorganic matter, IIM- 
insoluble inorganic matter [4]. 
2.2 Activated sludge, parameters and efficiency  
Activated sludge (AS) is the biomass which is produced in raw or settled wastewater 
due to the growth of the organisms in aeration tanks in the presence of Dissolved 
Oxygen (DO). Sludge is so called activated, because the particles are teeming with 
bacteria and protozoa. Activated sludge is a process in the treatment of sewage where 
air or oxygen is forced into sewage liquid for the development of a biological floc that 
reduces the organic content of the sewage. The sewage, after sufficient treatment, 
excess mixed liquor is discharged into the settling tanks and the supernatant is run off 
for the further treatment prior to discharge. This phenomenon occurs mostly in all 
activated sludge plants. Some part of the settled sludge is returned to the head of the 
aeration system and remaining sludge is further treated before it is disposed. [8] The 
overall function of the activated-sludge process is to remove substances which have a 
demand for oxygen from the system. This process is followed by the metabolic 
reactions (synthesis- respiration and nitrification) of the microorganisms, the separation 
and settling of activated sludge solids for the creation of acceptable quality of secondary 
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wastewater effluent and the collection and recycling of microorganisms back into the 
system or removal of excess microorganisms from the system. [9] 
 
       
 
Influent  Effluent 
 
 
 Oxygen or Air 
 
  
 Sludge 
  
                                                          
    Excess (waste) Activated   sludge                Excess (waste) Activated    sludge 
   Figure  2.3. Typical activated sludge process. 
Typical activated sludge process is shown in a schematic form in Figure 2.3. 
When an influent enters inside the reactor basin, it comes out as an effluent forming the 
activated sludge in the intermediate stages. There are several parameters of activated 
sludge used in biological wastewater treatment. Mixed Liquor Suspension Solids 
(MLSS), Mixed Liquor Volatile Suspended Solids (MLVSS), Sludge Volume Index 
(SVI), Oxygen Uptake Rate (OUR) are the different parameters of activated sludge. 
These parameters are used to analyze the condition and quality of the sludge. Efficiency 
of the activated sludge process in treating wastewater can be examined by measuring 
the biochemical oxygen demand (BOD) of the wastewater before and after the activated 
sludge process. MLSS is a measure of inorganic and organic suspended materials 
present in the aeration basin. It is measured by filtering a known sample volume through 
a filter and weighing the mass difference. MLVSS is a measure of volatile suspended 
material present in the aeration basin. These are mainly the organic materials which are 
used as a measure of the concentration of microorganisms. It is measured by burning the 
MLSS sample in 550 degree centigrade and weighing the mass difference. Sludge 
Volume Index (SVI) is a measure of settling capability of activated sludge. It is an 
experimental result which is useful in routine process control. This is measured by 
letting a volume of one liter of sludge settles for 30 minutes, reading the level of sludge 
(sludge volume at 30 minutes, SV30) and dividing it by MLSS. This is reasonable for 
the sludge volume 300 ml, if the amount exceeds the sample is diluted and the same 
process is repeated that gives the Diluted Sludge Volume Index, DSVI. [12] 
Reactor 
Basin 
 
Settling 
Basin 
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                                                                                                                  (1) 
 
Equation (1) gives the mathematical expression about how to calculate the Sludge 
Volume Index (SVI). SVI can be obtained by dividing SV30 by MLSS value. OUR 
(Oxygen Uptake Rate) is another important parameter of the activated sludge which is 
discussed later in the different chapters. 
Biochemical Oxygen Demand (BOD) is a measure of oxygen usage by a water 
sample in a specific time. The oxygen is used by the biochemical degradation of 
dissolved and suspended oxidable matter in water. BOD is an approximation of easily 
degradable matter which is used to evaluate the water quality and water treatment 
efficiency. [12] 
  2.2.1 Biochemical aspects of Activated Sludge 
 
Microorganisms are mainly present in the biological component of the activated sludge. 
There composition is 70 to 90 percent organic matter and 10 to 30 percent organic 
matter. Their types depend upon the chemical composition of the wastewater and the 
specific characteristics of the organisms in the biological community. Microorganism 
play an important role in the activated sludge process, they help in removing 
carbonaceous organic material and nitrifying ammonia in secondary influent 
wastewater. There are two levels of structure present in the activated sludge flocs. One 
is microstructure and another is macrostructure. Microstructure consists of microbial 
aggregation, adhesion and bioflocculation. As the meaning of bioflocculation is not 
clear, it is felt to be the result of bridging between extracellular microbial polymers. 
These polymers function as polyelectrolytes such as substances of high molecular 
weight like proteins which is an ionic conductor. Those extracellular microbial 
polymers form the envelopes like structure around the cells and group of cells. [9] 
There is the production of organic compounds and inorganic compounds due to 
the anaerobic activity in sewer systems. Mostly, malodorous compounds like volatile 
organic compounds (VOCs), volatile fatty acids (VFAs), volatile sulfur compounds 
(VSCs) and the inorganic gases like ammonia (NH3), hydrogen sulfide (H2S). Organic 
compounds are degraded by bacteria for obtaining carbon for cellular growth and 
reproduction and energy for cellular activity. Bacterial growth causes increase in the 
biofilm that covers sewer mains. Carbon atoms and electrons are released as chemical 
bonds due to the bacterial degradation of organic compounds. New cellular materials 
are produced from these carbon atoms and the electrons are used to obtain energy 
during electron movement from one protein molecule to another in an electron transport 
system. These electrons are removed from the cells at last. Several molecules are used 
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by bacteria to remove the electrons from the cells. These molecules consists of free 
molecular oxygen, nitrate ions (NO3-), nitrite ions (NO2-), sulfate ions (SO4=) and an 
organic compound. [13] 
Activity measurements of enzymes have been done in the microorganism 
population in the activated sludge. The enzymatic activities of the activated sludge that 
come from different WWTP show a high ability of microorganisms to change 
polyphosphates. These activity measurements studies shows that the suitability of the 
activity measurement which defines the potential possibility of a microorganism 
population for carrying out biological phosphate removal by the activated sludge 
method. [14] 
2.2.2 Microbiological aspects of Activated sludge 
 
The microbes convert carbon into cell tissue and oxidized the end products which 
includes carbon dioxide (CO2) and water. Along with this, a limited number of 
microorganisms may exist in activated sludge which gets energy by oxidizing ammonia 
nitrogen to nitrate. This process is called nitrification. Majority of the microorganism 
are present in the activated sludge. Heterotrophic bacteria are predominant which 
require organic compounds for their supply of carbon and energy in activated sludge. 
On the other hand, it consists of autotrophic bacteria that occur in proportion to 
concentrations of carbon and nitrogen. Aerobic and anaerobic bacteria may exist in the 
activated sludge; facultative species are preponderance which can live in absence r lack 
of DO (Dissolved Oxygen). Fungi, rotifers and protozoan are also present in the 
activated sludge. They may be ciliated or flagellated protozoan and amoeba is also 
present. These protozoans are the indicators of the activated sludge condition. Viruses 
of human origin are also found in raw sewage influent [9]. In Figure 2.4, different kinds 
of microorganisms are shown such as bacteria and parasites. 
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Figure 2.4. Figure showing the wastewater micro life [10]. 
Major nutrients in sewage are nitrogen and phosphate. In Finland the phosphate 
is removed chemically. Biological nitrogen removal is the important part of the 
activated sludge processes in Finland. Initially in the activated sludge process the 
biomass is ammonificated to ammonia and then it is nitrificated to nitrite and further to 
nitrate which forms nitrogen gas through denitrification. Another method is the Anamox 
reaction in which the nitrogen is removed biologically where ammonia ion and nitrite 
ion forms nitrogen gas. Nitrosomonas aeuropea and Nitrobacter species bacteria are 
said to be mainly responsible for nitrification. [11] 
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2.3. Comparative study of different types of toxicity tests 
Microbial population in an activated sludge is a heterogeneous community which is in 
equilibrium and helps the treatment plant to be flexible with respect to plant operational 
changes, flow, temperature and wastewater composition variations etc. Toxic chemicals 
may inhibit the activity of activated sludge which causes the loading shock to the 
system causing in lower treatment efficiency or the breakdown of the system as well. 
[16] 
Conventional parameters such as chemical oxygen demand and suspended solids 
are not useful for detecting toxic compounds that are present in the industrial 
wastewaters and treated wastes. Therefore, due to the toxicity in many industrial wastes 
causes more effect on biological wastewater treatment process. It causes adverse effects 
on receiving waters bodies [15]. Thus there are different techniques implied for the 
toxicity tests in the biological wastewater treatment process. 
Microtox test 
Microtox assay is based on the naturally occurring luminescent marine bacterium Vibrio 
fischeri that consists the constitutive promoter controlling the luxCDABE gene. 
Luminescence of V. fischeri is repressed in the presence of toxicants. It responds to the 
toxicants in a ‘‘lights off’’ fashion. [17] 
Microtox test is an acute toxicity test. It offers the greater sensitivity, 
repeatability and precision. These tests are used to study the pinpoint unusual 
wastewaters, evaluate the toxicity reduction through activated sludge processes. It is 
also used in observing the effect of increased chemical addition to meet the 
transparency standard, and also to measure the impact of waste discharge on one 
particular receiving water [15]. It is a common toxicity tool for the screening of 
wastewaters discharged into wastewater treatment plants. In one of the study performed 
by Gutierrez [16], Microtox was proven of having the higher sensitivity to toxicants but 
it was fewer representatives of effects on activated sludge compared to respiratory 
technique of toxicity test. In one assay related with LAS (Linear Sodium 
Dodecylbencene Sulfonate), a biodegradable reference surfactant showed the toxic 
effect following Microtox test whereas respirometry technique performed a good 
biodegradability but no toxicicity effect. [16] 
Daphnia magna test 
Daphnia magna is an acute toxicity tests which is performed by using daphnid Daphnia 
magna. This test is based on the bioluminescence method. It is an ecotoxicity assay for 
ecotoxicity evaluation of wastewater. Current legislation contains various parameters 
for water quality control which includes ecotoxicity determination by reference test like 
Daphnia magna mobility test. [16] 
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Nitrification inhibition tests 
Nitrification assays are generally performed using nitrifying activated sludge or purified 
nitrifying bacteria. The disappearance of ammonium-containing substrate and the 
appearance of nitrite or nitrate can be monitored and used to asses nitrification 
inhibition. It is essentially an oxidation process and requires oxygen. Nitrobacter assay 
was used for toxicity identification and evaluation of nitrification inhibiting substances 
in industrial wastewaters [17]. Microtox and nitrification inhibition tests are too 
sensitive for screening toxic chemicals. [16, 17] 
OUR (Oxygen Uptake Rate) 
OUR measurement is a useful test for the evaluation and regulation of the process 
performance. It is mainly used as the toxicity test in biological wastewater treatment 
plant. By determining the oxygen consumption rate during a limited period of time, the 
oxygen uptake rate can be calculated. The OUR measurements are not very difficult to 
perform practically but it needs the more effort for interpreting the results into useful 
information. [5] 
Oxygen Uptake Rate is a respirometric test. It measures the toxicity effects of 
different chemicals on activated sludges. Ubey [16] has explained the respirometric 
analysis of synthetic domestic sewage along with textile, dairy, meat processing, 
tannery and confectionary wastewaters. This was done for the experimental assessment 
of the readily biodegradable COD which includes the accuracy and reliability of the 
method. [16] 
Respirometry techniques characterize the toxicity of the effluents better than 
other techniques. Activated sludge respirometric tests are more direct method for 
assessing sludge activity and toxicity to sludge comparing to bioluminescence methods 
of toxicity tests. Different activated sludge respirometric techniques are well established 
and several standardized tests have been existed for a long time. For example, 
Organization for economic co-operation and development (OECD), 1984, 
Environmental Protection Agency (EPA) 1996, International Organization for 
Standardization (ISO) 1986. [20] 
Table 2.1 is shown inorder to see the criteria for influent wastewater toxicity 
monitoring. These comparisons of the different assays and devices can provide the 
useful information. It is shown that no single method has fulfilled all the criteria. 
Criterion 1 shows the bioassay based system that indicates overall toxicity without 
analyzing individual components of wastewater samples. Likewise different criterion 
shows different information in Table 2.1. 
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Table2.1. Summary evaluation of methods a for assessing wastewater toxicity to activated sludge b. [17] 
Number Criterion Biolumines
cence 
methods 
Respirometric 
Methods c 
Respirometric 
Methods(nitrificati
on/ 
denitrification) 
 
 
 
1 
 
Overall toxicity 
 
+ + +  
2 
 
 
Predict process 
upset 
 
? ? ?  
3 
 
Identify source 
 
- - -  
4 Rapid response + - -  
5 Anaerobic/aerobic - + +  
6 Concentration-
response 
+ + +  
7 Depict corrective 
action 
? ? ?  
8 Ease to 
operate/maintain 
- - -  
9 Accurate 
interpretation 
+ + +  
10 Function in 
complex matrix 
? + +  
11 Cost effective ? ? ?  
12 Detect false 
positive/negatives 
? ? ?  
13 Active/sleep mode 
switching 
+ + +  
14 
 
Commercializable ? + +  
 
aOnly methods reviewed in this manuscript were included in the evaluation. 
bThe same sumbols were as in Love and Bott (2000): ‘‘ +’’ indicates that method meets 
the criteria, ‘‘ -’’ indicates that method does not meet the critera, and  ‘‘ ?’’ indicates 
further investigation is necessary to assign ‘‘ +’’ or ‘‘ -’’. 
cMethod excludes nitrification/denitrification inhibition assesment. 
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2.4. Oxygen Uptake Rate (OUR) measurement for application at 
waste water treatment plants. 
The toxic compounds can inhibit growth or respiration in heterotrophic bacteria present 
in the wastewater. There are different ways by which the inhibitory compounds can act. 
They can be inhibitory to their own biodegradation or they may influence the rate of 
biodegradation of other compounds. Respiration involves the breakdown of simple 
organic carbon molecules. The end product is carbon dioxide and water. The nitrifying 
bacteria, chiefly Nitrosomonas and Nitrobacter, oxidize ammonia to nitrate and then to 
nitrite [18]. The steps are: 
 
                                                                              
               (2) 
 
Equation (2) shows the oxidation of ammonia to nitrate and then to nitrate. When 
growth is inhibited, the energy requirements will decrease; as a result there will be 
decrease in the respiration rate. Therefore less carbon is required for the respiration 
which results in decrease in biodegradation. Therefore, when there is toxicity, there will 
be inhibition in both the respiration rate and the biodegradation rate. [19] 
2.4.1 Respirometric techniques  
 
Respirometry is the process of measuring the biological oxygen uptake rate in aerobic 
conditions and interpreting the result. It is also the measurement of biogas generation 
rate in anaerobic environment. Respirometric methods are associated with the activated 
sludge in the wastewater. [21, 22]  
The first application of respirometric technique was used for measuring the 
oxidation of wastewaters. It was reported in 1924 by Otto Heinrich Warburg (1883-
1970). Manometry was the respirometry technique. Many researchers have developed 
different kinds of respirometric measuring techniques on manometric, electrolytic or 
direct measurement of oxygen consumption based on Warburg’s respirometer. Modern 
invention of automation and instrumentation has widened the applications of 
respirometer in optimizing and operation of wastewater treatment systems and waste 
management and biodegradation researches. [23, 24, 25] 
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Figure 2.5. Schematic representation of a typical oxygen uptake profile recorded with the developed nitrification 
activity determination method. [26] 
Respirometry is a useful mechanism for identification of the compounds which may 
potentially have an adverse effect on a wastewater treatment plant. The figure 2.5 shows 
the activity measurements result in oxygen uptake profiles. This shows the rapid, simple 
and robust method for the determination of NH4+-N and NO2- -N oxidation rates by 
measuring the OUR of mixed liquor samples before and after adding the selective 
nitrification inhibitors. ATU (Allylthiourea) and NAClO3 (Sodium Chlorate) are the 
selective inhibitors of Nitrosomonas Nitrobacter species. This method is validated on a 
SBR (Sequential Batch Reactor). [26] 
2.4.2 Oxygen Uptake Rate (OUR) Principle 
 
During the respiration of microorganisms, bacteria convert the energy from the organic 
substrate to high energy compound ATP. In the substrate, the electrons are removed by 
oxidation. These electrons are transferred along an electron transport chain to the 
terminal electron acceptor i.e. oxygen in the aerobic respiration. In this process the ATP 
is generated, so the process is called oxidative phosphorylation. These ATPs are used by 
bacteria as an energy source for the synthesis of different molecular compounds that are 
necessary for cell growth and reproduction. Nearly half of the substrate molecules are 
converted into new biomass in activated sludge. [22] 
Oxygen uptake Rate is directly related to the dissolved oxygen (DO). DO 
concentration is generally used to control activated sludge process with the help of 
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information about growth and substrate utilization in addition with the respiration rate-
based control comparison. [22] 
Oxygen Uptake Rate is the uptake of oxygen by activated sludge 
microorganisms per unit volume of sludge, in unit time. In the presence of a suitable, 
easily biodegradable substrate, activated sludge will consume oxygen rapidly. Addition 
of toxic concentration of a test material can result in the decrease in oxygen 
consumption rate as shown in Figure 2.7. The rate is measured with an oxygen 
electrode. The percentage inhibition of the oxygen consumption can be estimated by 
comparing a control mixture which doesn’t contain a test material [20]. EC50, EC20 
and EC10 values are used in respiration inhibition and nitrification inhibition tests for 
representing the concentration of wastewater (%) which produces 50%, 20% and 10% 
inhibition of the oxygen uptake rate in comparison to the control sample. [28] 
 
 
 
 
 
Figure  2.6. Illustration of the principle of the OUR measurements. [5] 
 
Oxygen uptake rate measurements provides the information related to treatment plant 
performance, wastewater characteristics, degradability of special concentrated streams 
and also the parameters required for mathematical models for the prediction of possible 
optimizations of a treatment plant.[5] 
The Specific Oxygen Uptake Rate (SOUR) is known as the oxygen consumption 
or respiration rate. It is defined as the milligram of oxygen consumed per gram of 
volatile suspended solids (VSS) per hour. This is a quick test which has many 
advantages. It rapidly measures the influent organic load and biodegradability which is 
the indication of the presence of toxic or inhibitory wastes. It also provides the degree of 
stability and condition of a sample, and calculation of oxygen demand rates at various 
points in the aeration basin. This test was originally developed as a plant control 
parameter. [27] 
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2.4.3 OUR Method 
 
Aerated activated sludge containing necessary nutrients and nitrification inhibitor is 
used for OUR measurement. Nitrification inhibitor is used to eliminate the oxygen 
consumption due to nitrification. There will be decrease in oxygen concentration for 
some minutes are noticed. The relationship between the decrease in oxygen 
concentration and time is normally seen to be linear as shown in Figure 2.6.  
 
Figure 2.7. A plot of the Oxygen concentration during repeated aeration in activated sludge with addition of acetate 
after 0.8 h. [5]. 
The OUR can be determined by calculations of the slope of the curve. Specific 
oxygen uptake rate is obtained if the oxygen uptake rate is associated with the volatile 
suspended solids (VSS). OUR can be followed longer by alternating the aeration of the 
sludge in intervals. OUR equipment is also called respirometer consists of a basic 
system which needs manual data collection and calculation. But more advanced 
commercial systems which are computerized and calculations can be done automatically 
have been used these days. However the types and the operating mechanisms are 
different. The essential components that includes are a test chamber for adding aerated 
mixed liquor, a stirring mechanism, a dissolved oxygen probe and a dissolved oxygen 
analyzer as shown in Figure 2.8. [29] 
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Figure 2.8 Schematic diagram for the test equipment for OUR determination. 
In the laboratory OUR can be measured by using a closed container and measurement of 
dissolved oxygen is taken by using an oxygen electrode and meter, when there is no 
mass transfer with the environment. [22] 
2.4.4. Factors affecting Oxygen Uptake Rate 
 
Different experimental conditions should be applied while performing the OUR test. 
Alterations in these factors may affect the OUR test results. Different factors that affect 
the OUR measurements are carbon source, pH, Nitrification inhibitor and Temperature.  
OUR is different with the different kinds of organic substrate so it is very 
important to use the same substrate. Same substrate should be used to compare the 
capacity of different activated sludge. Generally, acetate is used as a reference substrate 
because it is very easily degradable organic matter for heterotrophic bacteria. Therefore 
carbon source is one important factor in OUR test. Another factor is pH. The aerobic 
degradation of organic matter depends upon the pH 6 to 8. pH will slightly increase 
because CO2 is produced during oxygen respiration. Normally, there is no need of 
adjustments for pH stabilization. Temperature is another factor in OUR measurements. 
Generally OUR increases with the increase in the temperature so it is very important to 
keep the temperature constant in the whole experimental period. Generally the 
laboratories experiments are performed in 20˚C. [5] 
Another factor is the nitrification inhibitor. It is used only when the sludge has 
been obtained from the nitrifying treatment plant. In such Sludge, the oxygen 
consumption depends upon the oxygen used for nitrification instead of oxidation of 
organic matter. So nitrification inhibitor is used to prevent nitrification during 
measurement of organic degradation. Allylthiourea (ATU) is generally used as 
nitrification inhibitor which inhibits the conversion of ammonia to nitrite. 
Approximately 12 mg/l is used for OUR test measurement. It has been shown that use 
of 10 mg/l of ATU has impact on the endogenous respiration of the sludge that finally 
results in the low OUR results. Therefore the amount may be different for different 
types of applications followed. [5] 
 
Computer 
Dissolved 
Oxygen 
Analyzer 
Stirred 
Aerated Mixed 
Liquor 
container 
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Mixing rate and the concentration of oxygen demanding material in the sample 
are the major factors that affect oxygen uptake measurements with the electrolytic 
respirometer these problems can be avoided by using simple procedures like increased 
mixing rate or enrichment of the oxygen in the air which is in contact with the sample. 
[34] 
2.4.5 OUR Applications 
 
Oxygen Uptake Rate (OUR) measurements were initially used in wastewater treatment 
plants for monitoring biological activity of conventional BOD removal systems. The 
most common use of OUR measurements by plant operators was to determine viability 
of the organisms. Oxygen Uptake Rate (OUR) testing is a simple, readily available, and 
familiar tool which can provide more information like monitoring, optimization and 
troubleshooting BNR (Biological Nutrient Removal) systems. [29] 
 
The respirometry test is well established these days and it is being used in both 
research and at wastewater treatment plants. Interpretation of the results is complex for 
this type of tests. OUR measurements are used for the characterization of wastewater 
streams in both the batch tests and online respirometry. This test is used in different 
wastewater streams such as municipal wastewater, concentrated organic streams from 
industries and internal recirculation streams from different parts of the treatment plant. 
OUR is applied in the variations in organic load/treatability in which it is useful for the 
plant operator to control and manage the plant in a more optimal manner. [5] 
OUR tests are explained to be more useful for characterization of industrial wastewater. 
It is important in wastewater treatment plants for continuous measurements and used as 
forward treatment strategy and also for plant performance control. [30] 
Graph 2.9 below shows that with a 100% concentration of the wastewater, the 
respiration rate is inhibited by 46% relative to the control. The EC50 is >100mg/l, EC20 
is 60mg/l and EC10 is 40mg/l. These values show that the wastewater is toxic. 
 19 
 
 
Figure  2.9. The plot of respiration inhibition vs wastewater concentration [28]. 
The most important application of OUR is the toxicity test and inhibition 
measurement of the wastewater streams. In Figure 2.10, the effect of adding toxic water 
to activated sludge is demonstrated. Addition of acetate results in the rapid increase in 
the OUR but the biological treated leachate water only shows a smaller increase when 
mixed to the activated sludge. The toxic wastewater results in the decrease in the OUR 
compared to the endogenous respiration level which indicate the decay or inhibition of 
the microorganisms in the sludge. [5] 
 
Figure 2.10.Toxicity test. Three parallel respiration tests, one with additions of acetate, one with biological pre-
treated leachate and one with toxic wastewater. Sludge from the same plant with identically conditions was used in 
all reactors. [5] 
Respirometry tests are important because the results can be received quickly. For 
obtaining more quantitative explanation of the toxic effect it is often used in 
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combination with EC50 measurement. EC50 represents the concentration of a 
compound where 50% of its maximal effect on the tested organism is observed. It will 
be more useful if the measurement is taken repeatedly at the same spot inorder to detect 
the changes in the result. Regular OUR tests at different places of the plant are useful in 
following the process performance. Continuous OUR measurement will help the plant 
operator for fast troubleshooting of process failures and process changes. [5] 
The importance of respirometric methods is that it is possible to measure the 
respiration activity easily and quickly. New technologically advanced respirometers are 
used for the  biodegradation measurements in water media and soils, for kinetic analysis 
and biokinetic constant determination, for modeling the wastewater treatment process, 
for managing toxicity, for measuring short-term BOD, nitrification capacity, activity of 
activated sludge, readily degradable BOD treatment capacity and aeration requirements. 
[21, 28] 
2.4.6. EC50 and its Interpretation 
 
 The toxicity of chemicals is generally expressed in terms of dosage that gives 50% 
effect to the response in comparison with the control. The effect can be more or less in 
response. This is called EC50 or Effective Concentration 50. It is also said to be 
Effective Dose 50 (ED50) or RD50 for dosage causing 50% inhibition or reduction .It is 
referred to as LD50 in animals, the dosage lethal to 50% of the subjects. The EC50 is 
generally estimated by fitting a log-logistic curve to the data. The model is a sigmoidal 
relation on a logarithmic scale rather than linear relation. The logistic model can be used 
to dichotomous data like survival or death and to continuous data such as weight or 
biomass, and can be expressed in terms of length for growth [31]. EC50 is a function of 
chemical concentration to construct a frequency distribution of the affected species. 
This is called as species sensitivity distribution (SSD). [32] 
A standard dose-response curve can be explained by four parameters. The 
baseline response (Bottom) the maximum response (Top), the slope, and the drug 
concentration provokes a response halfway between baseline and maximum (EC50). 
The definition can be simplified as the concentration of agonist which provokes a 
response half way between the baseline (bottom) and maximum response (Top). EC50 
cannot be defined without defining the baseline and maximum response. It is easy to 
misunderstand the definition of EC50. [33] 
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Figure 2.11 Standard dose response curve. [33] 
It is defined quite simply as the concentration of agonist that provokes a 
response half way between the baseline (Bottom) and maximum response (Top). An 
Agonist is a drug which causes a response and an antagonist is a drug which doesn’t 
cause response in itself. In Figure 2.11, response can be seen due to the agonist. It is 
impossible to define the EC50 until the baseline is first defined and maximum response. 
The baseline is about 20%, and the maximum is 100%, therefore the EC50 is the 
concentration of agonist which evokes a response of around 60% (half way between 
20% and 100 %). EC50 shouldn’t be overinterpreted. [33] 
2.5 Pharmaceuticals in the wastewater 
2.5.1 Pharmaceuticals  
 
According to EU definition a pharmaceutical, or a drug or a medicinal product is 
defined as any substance or combination of substances presented as having properties 
for treating or preventing disease in human beings. It can be also defined as any 
substance or combination of substances which may be used in or administered to human 
beings either with a view to restoring, correcting or modifying physiological functions 
by exerting a pharmacological, immunological or metabolic action, or to make a 
medical diagnosis. Human pharmaceuticals consist of variety of chemical structures. 
Approximately 3000 active components are used in Europe. Classification of 
pharmaceuticals is very difficult and it can be classified usually on the basis of chemical 
structure, pharmacological activity, physiological classification and receptor interaction. 
Each pharmaceutical consist of an active pharmacological compound. [38] 
 
Pharmaceuticals are biologically active compounds that are made for the 
treatment of different diseases. There are different methods of classifying 
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pharmaceuticals. The Anatomical Therapeutic Chemical (ATC) and the Defined Daily 
Dose (DDD) is the measuring unit which have become gold standard for international 
drug utilization research. The ATC/DDD system is a means for exchanging and 
comparing data at international, nationals and local levels. [38] 
The presence and the nature of the pharmaceuticals in wastewater treatment and 
the environment have created the more interest during the last decade. New 
pharmaceuticals are exponentially added in the large array of chemical classes in the 
markets. [35,36]. Different types of pharmaceuticals like anti-inflammatory drugs, lipid 
regulators, antibiotics, contraceptives, beta-blockers and tranquilizers have been 
detected in different water samples from river water, groundwater, wastewater and 
drinking water. [35, 36, and 37] 
Pharmaceuticals are generally classified as antibacterial, antiepileptics, anti-
inflammatory and antirheumatics, beta-blocking agents and lipid modifying agents. 
Antibacterials drugs were again classified into the Fluoroquinolones. They are 
Ciprofloxacin, Norfloxacin and Ofloxacin, Sulfonamide and the Sulfamethoxazole. The 
fluoroquinolones are used for the treatment of UTI (Urinary Tract Infections), 
respiratory infections, gonorrohea, bacterial prostatisis, cervicitis and anthrax. 
Carbamazepine is the widely studied antiepileptic drug. It is also used in the treatment 
of neuropathic pain and manic-depressive illness. [39] 
Diclofenac, Ibuprofen, Ketoprofen and Naproxen are classified as anti-
inflammatory and antirheumatics. They are also called non-steroidal anti-inflammatory 
drugs and are used worldwide for the treatment of rheumatic musculoskeletal 
complaints. Diclofenac and Ketoprofen are used as a therapeutic agent in different gels 
and sprays for treating muscle pain. Acebutolol, atenol and metoprolol are the beta 
blockers used for the treatment of angina, hypertension and dysrhythmias. Bezafibrate is 
a lipid modifying agent used in the treatment of mixed dyslipidaemia which is a risk 
factor for atheromatous disease. [39] 
Structure of the pharmaceutical industry includes research and development 
(R&D) to discover, enhance and devise reliable manufacturing processes of drugs, bulk 
manufacturing to produce large volumes of drug ingredients. Manufactured drugs are 
combined with drug ingredients in a form suitable for sale and use and marketing for 
promoting and selling drugs (e.g., by informing health care providers and consumers of 
their availability, features and proper use). There are three stages of pharmaceutical 
production which is shown below in Figure 2.12 
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Figure 2.12.The three stages of pharmaceuticals production, Adapted from EPA, 1992. Pharmaceutical 
Manufacturing Industry: Revision of Effluent Guidelines. Unpublished Status Briefing. Washington, DC: U.S. EPA. 
[56] 
 
The first stage of Figure 2.12 is the Research and Development stage which helps in 
discovering, enhancing and devising suitable manufacturing process for 
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pharmaceuticals.  A new drug needs many laboratories testing for years such as upto 12 
years as well. The second stage is the Bulk drug manufacturing stage which converts 
organic and chemical substances into bulk active ingredients with the help of many 
conversion processes like fermentation, extraction or chemical synthesis. Stage III 
includes the finished pharmaceutical product formulation which applies to the 
combination of bulk active ingredients with other substances for the production dosage 
forms which are suitable to intake by human or animal. Formulation means preparing 
the dosage forms into tablets, capsules, liquids, parenterals and creams and ointments. 
Hard and soft capsules contain gelatin capsules which are filled with active ingredient. 
[56] 
 
2.5.2 Major pharmaceuticals in the wastewater 
 
The wide use of pharmaceuticals like Carbamazepine and Diclofenac has made their 
presence in the wastewater. All the drugs are not removed effectively in the WWTP so 
they can be found in the water bodies. These drugs can be found in the WWTP 
effluents, surface waters, and ground water and sometimes in drinking water. These 
drugs have been detected in Europe and Asia and America. The concentrations of 
carbamazepine and diclofeanc are significantly different in different countries. It is due 
to the diverse consumption of rates of both pharmaceuticals in those countries. In some 
countries the higher concentrations of these drugs may not be found due to the 
insufficient investigations conducted. Carbamazepine concentrations in WWTP 
effluents are normally hundreds of nanogram per liter but sometimes it may occur in 
microgram per liter varying the values between different countries. Carbamazepine has 
been defined as anthropogenic marker in water bodies. [40] 
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Table 2.2. Physical, Chemical and Pharmacological properties of Carbamazepine and Diclofeanc. [40] 
  
Carbamazepine (CBZ)  
 
 
       Diclofenac (DFC) 
Pharmacology 
Structure, 
formula, CAS 
No. and 
molecular 
weight 
 
 
 
 
 
 
 
 
 
C15H12N2O  
298-46-4 
236.27 g mol-1 
 
 
C14H11Cl2NO2 
15307-86-5 
296.16 g mol-1 
Usage  Analgesic, antiepileptic Analgesic, anti-inflammatory 
 
Water 
solubility 
 
 
17.7 mg L-1 (25oC)       23.73 mg L-1  (25oC) 
Log P 
(octanol–
water) 
 
 
 
2.45 
 
– 
Henry’s Law 
Constant 
 
 
1.09 × 10-5Pa m3 mol-1 (25oC) 4.79×10-75Pa m3 mol-1 (25oC) 
P Ka  neutral 4.15 
Elimination 
half-life 
 
 
25–65 h  
 
2 h 
Excretion  72% of oral dosage excreted in 
urine, 28% in faeces 
Biliary excretion: 65% of oral 
dosage excreted in urine 
 
Metabolites in 
urine (%of 
oral 
dosage) 
 
 
CBZ, CBZ-epoxide, CBZ-diol, 
CBZ-acridan, 2-OH-CBZ, 3- 
OH-CBZ 
DFC, 5-OH-DFC, 4 -ˊOH-DFC, 
3 -ˊOH-DFC, 4 -ˊ5-diOH-DFC, 
4 -ˊOH-5-Cl- 
DFC, 3 -ˊOH-4 -ˊCH3O-DFC 
Dosage  Maintenance usually 800–1200 
mg daily 
75–150 mg daily 
Other 
Information 
 
 
Autoinduction, i.e., long term 
applications increase its 
metabolism 
Dermal applications available 
 
 
Many anthropogenic origin compounds and WWTP effluents are the significant 
points of discharges for the presence of endocrine disrupting compounds and residuals 
of pharmaceuticals in the rivers, streams and surface waters. Hence it is of great interest 
for eliminating these substances within the WWTP.  The aeration tank and the final 
clarifier form one process unit in the conventional activated sludge plants (CASP) and 
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the separation of treated sewage and sludge is done in the clarifier through 
sedimentation. So the capacity of sedimentation is important selection criterion. [41] 
In a review of Miege [46], about fate of pharmaceuticals, database was created 
for the assessment of the occurrence and removal efficiency of pharmaceuticals and 
personal care products with respect to their quantities. The database has allowed for the 
identification of the most investigated PPCP in WWTPs and the most persistent ones for 
obtaining reliable and quantitative values on their concentrations and also to obtain the 
frequency of the detection and removal efficiency in WWTPs. In the review they have 
allowed to indentify more than one hundred pharmaceuticals and PPCPs from different 
prescription classes measured in WWTPs of different countries like Brazil, North 
America, and European countries. This review contains analgesics and anti-
inflammatory drugs, antibiotics and bacteriostatics, anti-epileptics, beta blockers, blood 
lipid regulators, contrast media, cytostatics, hormones (including oral contraceptives), 
antidepressants and anxiolitics, musk fragrances, disinfectants and antiseptics. [46] 
Table 2.14. The pharmaceuticals and personal care products the most investigated in wastewater treatment plants. 
[46] 
Therapeutic class Molecules Frequency (%)a 
 
Hormone Estrone, 17β-estradiol, 17α-
ethinylestradiol, Estriol, 17α- 
estradiol, Testosterone, 
Progesterone 
    30 
Analgesic-anti-
inflammatory 
Ibuprofen, Diclofenac, 
Naproxen, 
Ketoprofen,Mefenamic acid 
    20 
Antibiotic Sulfamethoxazole, 
Trimethoprim, Ciprofloxacin, 
Roxithromycin, Norfloxacin, 
Clarithromycin, 
Erythromycin 
    8.7 
Lipid regulator Bezafibrate, Gemfibrozil     4.4 
Anti-epileptic Carbamazepine     4.0 
Metabolite Clofibric acid, Salicylic acid     3.9 
Beta-blocker Metoprolol, Propranolol, 
Atenolol 
    2.8 
Personal care product Galaxolide, Tonalide     2.7 
Contrast product Iopromide     1.1 
Disinfectant Triclosan     0.8 
Vasodialator Pentoxifyllin     0.7 
Antidepressant Diazepam     0.6 
Citation frequency for paracetamol and 0.3% for aspirin, bisoprolol and sotalol was only 
0.6%. 
Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) which is used to 
reduce inflammation and for relieving pain. It works as an analgesic in cases of arthritis 
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or acute injury. It is also used to reduce the pain during menstrual pain, dysmenorrhoea. 
Diclofenac is eliminated in a short period; its elimination half life is about 2 hours [40]. 
 
 
 
 
 
Figure 2.13. Chemical structures of Ibuprofen, Ketoprofen, Naproxen and Clofibric acid. [43] 
In a study by Tixier [43] about occurrence and fate of Carbamazepine, Clofibric 
acid, Diclofenac, Ibuprofen, Ketoprofen and Naproxen in surface waters, continuous 
concentration measurements were carried out in the effluents of three WWTPs, in two 
rivers, and in lake over a time period of three months. It was investigated that 
concentration time courses of the drugs in the effluents of the WWTPs, ranging from 
the limit of detection (1.5-10 ng/L, depending on the compound) to more than 3 µg/L. 
All compounds had the pronounced fluctuations in their concentrations. The highest 
concentrations were found for Naproxen and Ibuprofen in the effluent of WWTP. 
Clofibric acid and Ketoprofen presented in the lowest concentrations did not exceed 60-
180 ng/L. [43] 
 
Diclofenac, a non-steroidal anti-inflammatory drug most commonly detected 
pharmaceuticals in sewage treatment plant (STP) effluents. Biologically produced 
manganese oxides (BioMnOx) were investigated to remove Diclofenac. [44] 
Toxic Substances Hydrology Program of the U.S. Geological Survey (USGS) 
shows that many chemicals are found in residential, industrial, and agricultural 
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wastewaters. Generally they occur in mixtures at low concentrations downstream 
mainly in the highly populated and animal production areas. Human and veterinary 
drugs (including antibiotics), natural and synthetic hormones, detergent metabolites, 
plasticizers, insecticides, and fire retardants are the main chemicals. More than one 
chemicals were detected in 80 percent of the streams sampled, and 82 of the 95 
chemicals were detected at least once. Generally these chemicals were found at very 
low concentrations (in most cases, less than 1 part per billion   chemical mixtures were 
common; 75 percent of the streams had more than one, 50 percent had 7 or more, and 
34 percent had 10 or more . [45] 
 
Figure: 2.14. Total concentrations of the chemicals in microgram per liter [45] 
Steroids, nonprescription drugs, and an insect repellent were the three chemical groups 
most commonly detected in susceptible streams. Detergent metabolites, steroids, and 
plasticizers generally were found at the highest concentrations. [45] 
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2.6. The toxicity of drugs to the biological purification system 
Operation of any biological system is an adequate supply of oxygen is an important 
factor. Like humans cells also need oxygen to breathe not only the organic material as 
food. Biological degradation of the waste is not adequate with the less supply of 
oxygen. There are two types of biological wastewater treatment that are Mechanical 
method for creating contact between wastewater, cells and oxygen and another is 
without mechanical means that doesn’t include cells and oxygen. [47] 
 
There is a significant transformation of chemicals that occurs in nutrient-
removing wastewater treatment plants. The same performance are observed in 
configurations of the reactor as wide as conventional activated sludge, membrane-
bioreactors and suspended-biofilm reactors even though the average hydraulic retention 
time changes by factors of more than 10. [48] 
Activated sludge processes using WWTPs uses microorganisms for mineralizing 
the pollutants to water and carbondioxide or degrade them to the certain acceptable 
forms. Pollutants from the water can be removed by air stripping or by sorption onto 
sludge that is continuously discharged. So the removal of pharmaceuticals residues in 
activated sludge process consists of four mechanisms: Biotransformation, air stripping, 
sorption and photo transformation. [40] 
Diclofenac has a poor biodegradation rate. The sorption behavior of Diclofenac 
onto sludge is same like Carbamazepine. Removal efficiency of Diclofenac could be 
upto 80% and the carbamazepine below 10%. This is because the Carbamazepine is 
extraordinarily persistent to biodegradation at low concentrations and the 
biodegradation of Diclofenac may be possible under some conditions. [40] 
Ibuprofen doesn’t contain chlorine and double aromatic rings also absent in its 
structure. This makes it easier for the degradation. Removal of clofibric acid is poor as 
it contains chlorine in its structure. It is identified as a refractory contaminant in many 
investigations of municipal sewage influents and effluents. Membrane bioreactors are 
the efficient process for removal of Clofibric acid which would increase the feasibility 
of the technology. MBR is an advanced technology for the wastewater treatment 
process. [50] 
Table 2.15 below shows the toxicity data of Carbamazepine and Diclofenac in the 
literatures. The table shows the toxicity data for bacteria, algae, microcrustaceans and 
fish. Acute toxicity with EC50 concentrations, chronic toxicity with no observed effect 
concentration (NOEC) and predicted no-effect concentrations (PNEC) have been 
mentioned. Regarding predicted no-effect concentrations (PNEC), Carbamazepine has 
shown more hazardous effect showing the value of 0.42 µg L_1. [40] 
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Table 2.15. Toxicity data of Carbamazepine and Diclofenac in the literatures. [40] 
 Acute toxicity 
EC50 
 
Chronic toxicity 
NOEC 
 
PNEC References 
 
 
Carbamazepine 
 
 
 
 
 
 
 
Diclofenac 
 
>13.8–81 mg 
L_1 
 
1–10 mg L_1 
 
4.5–383.5 mg 
L_1 
 
75.1–502.6 
mg L_1 
 
11.5–22.7 mg 
L_1 
 
 
1–10 mg L_1 
 
3.3–142.2 mg 
L_1 
 
90 ± 20 µg 
L_1on zebra 
fish embryos. 
 
 
68 mg L_1 
 
 
 
25–100 mg L_1 
 
 
 
 
 
1–10 mg L_1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
45 mg L_1 
 
 
 
1mg L_1on 
Daphnia magna 
and 1 µg L_1on 
histopathological 
lesions 
 
 
0.42 µg L_1 
 
6.359 µg L_1 
 
 
 
116 µg L_1 
 
138.74 µg 
L_1 
 
Ferrari et 
al.(2003) 
 
Jones et 
al.(2002) 
 
Jos et al. 
(2003) 
 
Lavilleet 
al.(2004) 
 
Ferrari et 
al.(2003) 
 
Jones et 
al.(2002) 
 
 
Lavilleet 
al.(2004) 
 
Dietrich and 
Prietz (1999) 
 
Cleuvers 
(2004) 
 
 
 
 
Schwaiger et 
al. (2004) 
 
 
 
EC50: concentrations that cause 50% of effect. 
NOEC: no observed effect concentration. 
PNEC: predicted no-effect concentrations. 
The removal ability of each treatment process was evaluated based on the removal rate, 
calculated from the following expression 
R (%) = (Cin – Cout) / Cin ×100 
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Where, Cin and Cout are the concentration of the selected compounds in the raw 
wastewater and the effluent of each process, respectively. [49] 
Table 2.16. Influent and effluent concentrations and removal efficiency in sewage treatment plants (different 
equipment, different countries, sampling in different seasons. [67] 
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Data estimated from graphical data are in square brackets. n.r.: not reported. 
a Median concentrations or percent. 
b Average concentrations or percent. 
c Maximal concentrations or percent. 
In Table 2.16, Influent and effluent concentrations and removal efficiency in sewage 
treatment plants (different equipment, different countries, sampling in different seasons) 
of different pharmaceuticals are shown. The average elimination for particular 
pharmaceuticals ranges from only 7-8 % for Carbamazepine upto 81% for Acetyl 
salicylic acid, 96% for Propranolol and 99% for Salicylic acid. Lowest average removal 
rates were found for Diclofenac as 26%, for Bezafibrate 51%. This varies significantly 
between STPs. Naproxen was found having high removal rate of 81%.  This table shows 
that removal rates are not same even for the same pharmaceutical between different 
plants. 94-100% of Ibuprofen, Naproxen, Ketoprofen and Diclofenac was found in three 
STPs in the U.S.A. Mainly in the secondary treatment step, efficient removal takes 
place about 51-99% but in primary treatment only 0-44% were removed. [67] 
 
 
 
 33 
 
 
Gros [51] have studied removal of pharmaceuticals during wastewater treatment 
and environmental risk assessment using hazard indexes. Pharmaceuticals occur in 
WWTP effluents as they do not have tendency to adsorb onto activated sludge or 
because the microbial degradation may not be rapid to be completed in the hydraulic 
retention time of the plants. The range of removal rates (%RE) for the most 
representative compounds of each therapeutic group, in the whole set of WWTP under 
investigation is listen in Table 2.17. [51] 
 
Table 2.17. The range of removal rates (%RE) for the most representative compounds of each therapeutic group, in 
the whole set of WWTP under investigation. [51] 
 
There was an increase in concentration of the drugs along the passage through the 
WWTPs. The investigation showed that Macrolide antibiotics, Carbamazepine, 
Benzodiazepines and Serotonin reuptake inhibitors showed poor or no elimination in all 
WWTP. Diclofenac, as an exception, the removal rate was varied from no elimination 
upto 100%. The increase of Carbamazepine concentration in wastewater effluent occurs 
due to conversion of Carbamazepine glucoronides and other conjugated metabolites to 
the parent compound by enzymatic processes which happen in the treatment plant.  
When Lipid regulators, Fluoroquinolones, Tetracycline antibiotics are detected, and also 
Compounds Range of %RE Average %RE (± RSD) 
Sulfadiazine [43–98] 69 (± 32) 
Sulfamethoxazole [30–92] 74 (± 22) 
Norfloxacin [30–98] 57 (± 54) 
Ofloxacin [20–99] 40 (± 64) 
Ciprofloxacin [37–99] 66 (± 35) 
Tetracycline [40–89] 71 (± 33) 
Enalapril [83–99] 96 (± 11) 
Salbutamol [20–99] 60 (± 44) 
Famotidine [30–99] 50 (± 59) 
Ranitidine [50–98] 66 (± 39) 
Cimetidine [30–99] 50 (± 64) 
Glibenclamide [22–75] 46 (± 39) 
Nadolol [25–99] 60 (± 51) 
Atenolol [20–97] 59 (± 50) 
Bezafibrate [23–99] 69 (± 39) 
Gemfibrozil [30–99] 67 (± 48) 
Atorvastatin [40–80] 58 (± 44) 
Propyphenazone [30–87] 44 (± 68) 
Ketoprofen [40–100] 69 (± 40) 
Naproxen [60–100] 86 (± 13) 
Ibuprofen [65–100] 91 (± 13) 
Diclofenac [30–100] 58 (± 53) 
Acetaminophen [96–100] 99 (± 1) 
Salicylic acid [82–99] 96 (± 8) 
Furosemide [20–96] 50 (± 59) 
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cholesterol lowering statin drugs, histamine H1 and H2 receptor antagonists, β-blockers, 
β-agonists and the anti-diabetic glibenclamide were partially degraded which showed 
the removal efficiencies between 40 and 60–70%. [51] 
In one of the study by Quinn [52], the toxicity data of the pharmaceuticals were 
interpreted by using EU directive 93/67/EEC that classifies substances according to the 
measured effective concentrations (EC50 value). When this scheme was applied to the 
data that was obtained in their study Gemfibrozil, Ibuprofen and Naproxen were 
classified as toxic which have an EC50 between 1 and 10 mg/L. Carbamazepine, 
Bezafibrate, Sulfapyridine, Oxytetracycline and Novobiocin were all classified as 
harmful (EC50 between 10 and 100 mg/L) and Sulfamethoxazole, Trimethoprim and 
Caffeine were considered non-toxic (EC50N100 mg/L) as show in the table 2.18. These 
results are similar to other studies that included Ibuprofen, Naproxen, Gemfibrozil and 
Carbamazepine as high risk pollutants in WWTP effluents. [52] 
Table 2.18. Level of toxicity for each of the 11 pharmaceuticals under investigation, based on the chronic EC50 
results from Hydra attnuata in the current study using classification from EU directive 93/67/EEC. [52] 
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Table 2.19. Acute (LC50) and Chronic (EC50, LOEC, NOEC) responses (mg/L) with 95% confidence interval (CI) 
based on morphology for Hydra attenuate exposed for 96h to the 11 pharmaceuticals under investigation. [52] 
Pharmaceutical 96 h 
LC50 
95% CI 96 h 
EC50 
95% CI LOEC NOEC TT 
Carbamazepine 29.4 (32.83–
26.32 
15.52 (29.02–
8.3) 
5 1 2.24 
Bezafibrate 70.71 (70.71–
70.71 
25.85 NC 1 0.1 0.32 
Sulfapyridine > 100 NC 21.61 (34.23–
13.64) 
5 1 2.24 
Oxytetracycline > 100 NC 40.13 (46.95–
34.3) 
100 50 70.71 
Novobiocin > 100 NC NC NC 100 50 70.71 
Sulfamethoxazole > 100 NC NC NC 10 5 7.07 
Trimethoprim > 100 NC NC NC > 100 > 100 NC 
Caffeine > 100 NC NC NC > 100 > 100 NC 
NC= not calculable, results didn’t fit the appropriate test. Toxicity threshold 
TT= (NOEC× LOEC) 1/2 
Acute toxicity was based on the effect on morphology where the LC50 and EC50 values 
with their 95% confidence limits, are shown in above Table 2.19. 
 
2.7. Different methods of drugs removal from wastewater 
treatment plant 
DuPont has developed the PACTTM  process in the early 1970s for the removal of color 
from industrial wastewater. PAC (Powdered Activated Carbon) was added to an 
activated sludge reactor for removing compounds which were not degraded by the 
microorganisms and for providing better treatment which can only be obtained with 
tertiary treatment process. The study with PACTTM   has been used to determine whether 
the IC50 value for each specific inhibitory compound was greater for PACTTM sludge or 
activated sludge and to determine whether the carbon concentration and sludge age 
combination impacted the IC50 value.  PACTTM has been claimed to have the different 
benefits over conventional activated sludge systems. [53] 
• Improved process stability during shock loads by adsorption of soluble organic 
compounds 
• Improved COD removal by adsorption of non-biodegradable organic 
compounds 
• Improved color removal 
• Improved sludge settling, thickening and dewatering characteristics 
• Improved hydraulic capacity which is may be due to increased removal rates or 
operation with higher mixed liquor biomass levels 
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• Improved nitrification by either adsorbing inhibitors or providing a surface for 
the attachment of nitrifiers and 
• Improved removal of EPA priority pollutants. [53] 
Ozonation is one of the advanced techniques for waste water treatment and title of 
many recent Studies. Formation of OH radicals due to ozone decay in the water is the 
main mode of action in the Ozonation process, but there is also ozone molecules present 
for chemical attack. So the oxidation capacity will be increased. No oxidant residues 
remain as an advantage. 
 
  Ozonation has a good performance in removal of pharmaceuticals. 50% of the 
pharmaceuticals were removed during ozonation of conventional activated sludge 
(CAS) and membrane bioreactor (MBR) effluents with different ozone doses was 
shown in a study done in Germany. Sand Filtration (SF), Ozonation, 
Microfiltration/reverse osmosis (MF/RO) and Ultrafiltration are the other methods to 
eliminate the target compounds in the wastewater treatment plants. In a research by Sui 
[54], these methods were employed in two WWTPs for eliminating target compounds 
which proved very effective with the main contributions in removing micropollutants in 
wastewater treatment. [54] 
Table 2.20. Removal efficiencies (%) of target pharmaceuticals and consumer products by advanced treatment 
process in studied WWTPs. [54] 
COMPOUND WWTP 
A 
 
           
 
 WWTP B 
    
WWTP D 
 
 
UF OZONE  SF MF/RO 
           
     
DEET 0–50 50–80 0–50 
 
>90 
 
 
CF 
TP 
BF 
CA 
GF  
DF 
IM  
MA 
MTP  
CBZ 
SP 
 
 
 
<0 
0–50 
0–50 
<0 
0–50 
0–50 
0–50 
0–50 
0–50 
<0 
0–50 
 
 
 
 
 
50–80 
>90 
0–50 
50–80 
80–90 
>90 
>90 
80–90 
80–90 
>90 
>90 
 
 
 
 
<0 
80–90 
0–50 
<0 
50–80 
<0 
<0 
<0 
<0 
0–50 
0–50 
 
 
 
 
 
50–80 
>90 
>90 
80–90 
>90 
>90 
>90 
0–50 
>90 
>90 
>90 
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Table 2.20 shows the removal efficiencies (%) of target pharmaceuticals and consumer 
products by advanced treatment process in studied WWTPs. Higher HRT (Hydraulic 
Retention Time) (›12h) and SRT (Solid Retention Time) (›10d) can contribute to an 
increased removal rate of pharmaceuticals. In the secondary treatment, the average 
removal rate for different compounds ranged from -12% to 100%. Caffeine, 
Benzafibrate, Trimethoprim and DEET (N, N-Diethyl-meta-toluamide) were removed 
effectively with the average efficiency of 100 ±0%, 88±12%, 76±24% and 69 ±21% 
respectively. Caffeine was proved to be readily biodegradable. 28-53% of Diclofeanc 
was removed by a secondary treatment in the WWTPs that was between 26% in Finland 
and 69% in Germany. [54] 
O3 and O3/ H2 O2 processes are better for the treatment of pharmaceutical 
wastewater containing antibiotics. Investigations showed that Ozonation process is able 
of achieving high levels of COD and aromaticity removals at about their natural pH 
values. Mostly biodegradable fraction of wastewater can be increased by Ozonation that 
leads to the formation of low molecular weight oxygenated byproducts which are more 
amenable to biodegradation. Ozonation could be successfully used as a pretreatment 
step for improving the biodegradability of wastewater containing antibiotics. [55] 
 
Figure 2.15 Ozone process schematic diagram. [57] 
Figure 2.15 describes the working mechanism of the Ozone process. There are different 
steps shown in the schematic diagram which consist of ozone generation and 
wastewater in and other intermediate steps. Ozone is effective to destroy viruses and 
bacteria and it is more effective than chlorine. Ozonation process takes a very short 
contact time, approximately 10 -30 minutes. Ozonation process doesn’t leave harmful 
residuals as ozone decomposes very fast. Ozonation doesn’t let the microorganisms to 
regrow. [57] 
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Coagulation-flocculation and floatation is the another method to remove drugs 
from wastewater treatment. It is a physical means for enhancing separation in which 
metal salts like iron (III), chloride, or aluminum phosphate are added to water. This 
allows the precipitation of suspended solids and colloids. Lipophilic trace pollutants are 
adsorbed on colloids. This is the optional technique to remove the nonpolar 
pharmaceuticals from the wastewater. Floatation is used for separating fine solid 
particles from the aqueous phase by adhering them to the surface of upstreaming 
bubbles of air. This is also used to remove non-polar pharmaceuticals. Lipophilic 
compounds like Diclofeanc can be removed upto 70% during coagulation-flocculation 
method because of their significant sorption affinity. [58] 
Coagulation and flocculation process form removal of pharmaceuticals depends 
on a compound’s propensity to sorb to surfaces. As a result, hydrophobic compounds 
with high octanol-water partition coefficients (log Kow) can potentially be removed by 
coagulation/flocculation. But many pharmaceuticals are polar which have a smaller 
tendency to sorb to surfaces. For example, the log Kow values for Sulfamethoxazole 
and sulfamethazine are 0.89 and 0.28 respectively. So, their removal by coagulation is 
not significant. [60] 
 
In comparison with ozone-based Advance Oxidation Processes (AOPs), there 
are additional advantages of UV/ H2 O2 processes. They are: (1) relatively easy H2 O2 
storage and high thermal stability, (2) infinite H2 O2 solubility with water and no gas-
liquid mass transfer limitations,(3) reactions with organic compounds form peroxyl 
radicals which are also reactive that leads to succeeding oxidation reactions and (4) 
rapid installation and simple operation which is good for small water treatment plants . 
[60] 
 
Fenton System 
 
Researchers are interested  in separating the source of the refractory or toxic effluent 
and treat it by advanced oxidation processes (AOPs) by using homogeneous or 
heterogeneous catalyst. Fenton system Fen+/H2O2 is one of the most interesting 
oxidative techniques for the abatement of refractory and toxic organic pollutants in 
water and wastewater .This technique has the high removal efficiency which includes 
the formation of strong hydroxyl radical (HO) and oxidation of Fe2+ to Fe3+. Fe2+ and 
Fe3+ ions are both coagulants, therefore the Fenton process has dual function, oxidation 
and coagulation in the treatment processes. Iron is a easily available and non-toxic 
element. Also, hydrogen peroxide is environmental friendly. So this process has good 
efficiency in treatment processes for the removal of the refractory organic compounds 
from pharmaceutical industrial wastewater before being discharged into sewerage 
system. [62] 
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Anaerobic digestion 
 
Anaerobic digestion is another method which is particularly used for sewage treatment. 
It is contaminated with pharmaceuticals due to the municipal sewage origin. During the 
sludge cycling, pharmaceuticals are adsorbed to the sludge or dissolve in the high water 
content (>90%) can accumulate in the STP. This is the additional sludge digestion 
process where organic matter is degraded anaerobically under mesophilic (37.5°C) or 
thermophilic (55.5°C) conditions by a microorganism community.  Pharmaceuticals 
being adsorbed to the sludge or dissolved in the high water content (>90%) can 
accumulate in the STP during the sludge cycling or in the environment after disposal.  
Methanogenesis is the main metabolism process in anaerobic sludge digestion, which is 
not affected by Carbamazepine and Sulfamethoxazole in concentrations up to 400 mg/l. 
But Diclofenac can inhibit this process at high concentrations. [61] 
 
Pharmaceuticals investigated in the study of Carballa [61], were affected by the 
anaerobic digestion where Sulfamethoxazole (99%), Diclofenac (69%), Ibuprofen 
(41%), Iopromide (25%) were the average removal detected. They assumed that an 
increase in removal for some compounds like Diclofenac whose removal was increased 
to 80 % by extending the contact time. This was because of an increase in biodiversity 
of the degraders. The temperature of the process had a minor effect to pharmaceutical 
removal instead. [61] 
2.8. Fate and Effects of Pharmaceuticals in the environment 
The main effect of the occurrence and fate of pharmaceutically active compounds 
(PhACs) is in the aquatic environment. It is one of the emerging issues in environmental 
chemistry. In the countries like Austria, Brazil, Canada, Croatia, England, Germany, 
Greece, Italy, Spain, Switzerland, The Netherlands, and the U.S., more than 80 
compounds, pharmaceuticals and several drug metabolites, have been detected in the 
aquatic environment. [63] 
 
In sewage influent and effluent samples and in different surface waters situated 
downstream from municipal sewage treatment plants, the pharmaceuticals have been 
detected upto gram per liter level. Insufficient treatment of the wastewater results in the 
contamination of drugs in the receiving water bodies. Polar PhACs such as Clofibric 
acid, Carbamazepine, Primidone or Iodinated contrast agents can leach through the 
subsoil. They are detected in several groundwater samples in Germany, under recharge 
conditions. [63] 
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Figure 2.16. Scheme showing possible sources and pathways for the occurrence of pharmaceutical residues in the 
aquatic environment. [63] 
Figure 2.16 shows the schematic diagram for the possible sources and pathways for the 
occurrence of pharmaceutical residues in the aquatic environment. The possible sources 
are the medicines used for the human use and the animal use. Medicinal product for 
animal use occurs through excretion and waste disposal and also the medicines for 
animal use come in contact with soil through excretion. These medicinal products 
finally mix with the surface water and ground water. These are then received into 
drinking water, aqua cultures and pharmaceutical production plants. [63] 
 
‘Metabolite’ word is used for compounds that are resulted from the structural 
change of pharmaceuticals within the human body and not differentiating biochemical 
processes performed by human enzymes because of the bacterial activity in the gut and 
the ones that are present in the skin or non-biotic processes like hydrolysis in the 
stomach. So the metabolites may be formed by biological or non- biological processes. 
 
The chemical structure of the active molecules can be changed with the 
metabolism process, by biotransformation, biodegradation, and non-biotic 
transformation such as photo transformation and hydrolysis. Such a structural change 
brings a change in their physico-chemical and pharmaceutical properties. This 
phenomenon helps in the elimination of pharmaceuticals easily. [64] 
 
Generally, effluent from drug manufactures contains extremely high levels of 
pharmaceuticals. Drugs are commonly detected in effluents at levels from below 1 ng/L 
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up to a few µg/L. Reduced overall performance of the treatment plant is due to the 
toxicity of the pharmaceuticals to the microorganism in the plant. Mixture of residual 
fluoroquinolones may severely affect the microbial flora downstream from the plant. So 
there are many reasons of treatment process other than normal biological treatment for 
the removal of high levels of antibiotic residues from wastewater. [65] 
 
Occurrence of pharmaceuticals in the environment causes ground water 
pollution. The findings and the distribution of organic compounds originating from 
waste from the pharmaceutical industry in the down gradient of a landfill. 
Contamination of tap water by Clofibric acid is a common example. Another is the river 
water pollution, sediment pollution. Different findings have shown the presence of 
antibiotics in sediment cores from medication in fish farms. Ocean pollution and the soil 
pollution are the other effects of pharmaceuticals. Soil pollution can be caused by the 
use of manure to agricultural soils, multiple drug resistance developed in livestock 
micro flora. [65] 
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3. Materials and Methods 
The laboratory work can be classified as experimental set up, OUR and MLSS 
procedure, screening of Active pharmaceuticals and selection of inhibitory compounds, 
calculation of OUR, calculation of MLSS and MLVSS and calculation of EC50 
concentration. 
3.1. Sample collection 
Different pharmaceuticals were obtained from the pharmaceutical company called 
Universal Corporation Limited, Nairobi, Kenya. It is an investee company of Finland. 
The company produces off- patent generic drugs, including AIDS, Malaria and 
Tuberculosis treating drugs. The samples arrived in the laboratory in January 2010. 
Active ingredients were made into different solutions according to their solubility and 
standard concentrations. [68] 
Different solutions were made and brought in the laboratory for OUR 
measurements. OUR measurements, MLSS measurements, MLVSS measurements were 
done for all the samples inorder to check the toxicity of the samples towards activated 
sludge. Activated sludge was brought from the Tampere Wastewater treatment plant. 
3.2. Drugs 
Drugs were delivered in the laboratory in four batches. Each batch contains certain 
numbers of pharmaceuticals. The names of the pharmaceuticals and the number batches 
are mentioned with their serial number and concentration in a table form 
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Table  3.1. First batch of Chemicals 
S.N Raw Materials Concentration 
(g/L) 
160 Ai Quinine Sulphate B.P 0,5 
61 Ai Diclofenac Diethyl Ammonium 1 
37 Ai Cetrimide 1 
120 Ai Metformin Hcl 1 
19 Ai Ascorbic Acid BP 1 
44 Ai Chlorpheniramine Maleate 1 
231 Ex Caustic Soda Pearls(Sodium 
Hydroxide) 
1 
85 Ai Folic Acid 0,5 
33 Ai Caffeine 1 / Caffeine Anhydrous 
2 
1 
10 Ai Ammonium Chloride 1 
106 Ai Levamisole HCL 1 
63 Ai Diclofenac Sodium 1 
228 Ex Camphor 0,5 
166 Ai Salicylic Acid 1 
65 Ai Diphenhydramine HCL 1 
356 Ex Sugar White 1 
92 Ai Guaiphenesin B.P 1 
55 Ai Cyanocobalamine B.P/ U.S.P 1 
82 Ai Ferrous Sulphate 1 
20 Ai Aspirin 1 
33 Ai Caffeine 1 / Caffeine Anhydrous 
2 
1 
71 Ai Ephedrine HCL B.P 1 
 
Table  3.2. Second batch of Chemicals 
S.N Raw Materials Concentration 
(g/L) 
137 Ai Paracetamol BP 
(Acetaminophen) 
1 
38 Ai Cetrizine (Cetirizine, Zyrtec) 0.1 
96 Ai Ibuprofen 20 Microns 0.01 
115 Ai Mebevarine B.P 1 
12 Ai Amodiaquine HCl 1 
159 Ai Quinine Dihydro Chloride 0.1 
143 Ai Phenytoin Sodium 0.01 
68 Ai Doxycycline Hcl 0.1 
9 Ai Amminosidine (Paromomycine) 1 
98 Ai  Ibuprofen B.P 0.01 
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Table  3.3. Third batch of Chemicals 
S.N Raw Materials Concentration 
(g/L) 
165 Ai Salbutamol Sulphate 1 
26 Ai Benzoic Acid 1 
105 Ai Lamivudine 1 
133 Ai Omeprazole Magnesium 0.1 
147 Ai Potassium Chloride 1 
40 Ai Chloramphenicol B.P 1 
21 Ai Atenolol 1 
36 Ai Cimetidine 1 
 
Table  3.4. Fourth   batch of Chemicals 
S.N Raw Materials Concentration 
(g/L) 
149 Ai Povidone Iodine B.P (PvP-
iodine, Betadine) 
1 
94 Ai Hydrocotisone Acetate 0.1 
185 Ai Thiamine HCL (B1) B.P 1 
242 Ex Citric Acid (anhydrous) 1 
127 Ai Nicotinamide B.P 1 
332 Ex Propyl Paraben Sodium 1 
326 Ex Povidone K- 30 1 
197 Ai Zidovudine 1 
163 Ai Riboflavine B.P 1 
186 Ai Thiamine Mononitrate 1 
 
3.3. Experimental set up  
Different solutions and apparatus required for carrying out the experiment was set up on 
the bench in the laboratory. The apparatus that were used in performing the test are as 
follows: 
Glasswares 
• Glass pipette 
• Erlenmeyer flasks with stoppers (100 mL,200mL,500mL and 1000 mL) 
• Volumetric flasks (500 mL and 100 mL) 
• Beakers 
• Magnetic stirrers 
• BOD bottles (500 mL) 
• Pasteur pipettes 
• Measuring cylinder 
• Stop watch 
• Container with activated sludge 
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Those glassware were used in each step while performing the OUR test and MLSS 
procedure. OUR apparatus was made ready in the working bench. Solutions to be tested 
were stored in the cold room. 
Apparatus and Solutions for carrying out OUR, MLSS and MLVSS procedures are 
described below. 
3.4. OUR and MLSS methods 
3.4.1 OUR method 
Apparatus needed: 
• Test vessel of 293 ml with a cover 
• Oxygen meter WTW Multiline P4 
• Oxygen probe CellOx325 
• Magnetic stirrer 
• Overflow bowl 
• Laptop with WTW MultiAchat II program 
• 1 L volumetric flask 
• Measuring cylinder for activated sludge 
• 500 mL Erlenmeyer flask. 
 
A nutrient solution was prepared by dissolving the following ingredients into 
1000 mL tap water in a volumetric flask. The constituents and the quantities are 
shown below in Table 3.5 
 
Table 3.5. Nutrient solution 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Constituents Quantity 
 Peptone 
 
Dextrose C6H12O6 
 
Urea OC(NH2)2 
 
Dipotassium hydrogen phosphate K2HPO4 
 
 
16g 
 
16g 
 
3g 
 
2.8g 
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Preparation of OUR equipment 
MultiAchatII program was started. At first, Start was selected and then Select- meter-
COM and Configuration. Kind: Oxygen was choosed and the Type: Oxi325. Interface 
was choosed as COM1. File was choosed and clicked save continuously and then file 
was named (e.g.100216.dbf). Edit was choosed and right mouse button was clicked in 
the Graphics window. Configure was choosed as Carriage 1Spc/h and timer was clicked 
and choosed 10 s between measurement. 
Oxygen meter was calibrated while the CellOx325 probe was in the white 
storage sleeve. CAL was pressed and RUN/ENTER was clicked. The AR sign started 
flashing and O2 was pressed when AR stopped flashing. The device was ready for the 
measurement of Dissolved Oxygen (DO) level. 
Injection volume required for each measurement was calculated for each 
chemical, blank and sludge with chemical. The stock standards of the active ingredients 
were made ready as working standard for OUR measurements. 
 
Figure  3.1. The test equipment for OUR determination (a) 
Figure 3.1 shows the test equipment for determination of OUR which was used in the 
laboratory. 
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Figure 3.2. The test equipment for OUR determination (b) 
 
Procedure 
Generally the test was carried out in 9 different steps in which four steps consisted of 
nutrient control, chemical control with 3 different concentrations starting from low 
concentration to high was tested. The next five measurements included sludge except 
two of them which only contained tap water, nutrient solution and activated sludge. 
Those two were taken as sludge controls. The other three had a constant volume of 100 
mL of sludge and the different chemical concentrations mixed. 
Each chemical was tested for its inhibitory action towards activated sludge. 
Different volumes of chemical and sludge were measured to know whether the chemical 
was toxic or not. For this, the nutrient solution which consisted of Peptone, Dextrose, 
Urea and K2HPO4 was used in the same amount in each step of test, i.e. constant volume 
of nutrient solution was added on control, chemical blank, chemical with activated 
sludge and sludge controls.  The overall volume per sample was made 500 mL The 
measurement frequency was set to 10 seconds per measurement. Each measurement was 
terminated either if the oxygen level dropped below 2 mgO2/ L or after 10 min. In the 
first four however the measurement was also stopped earlier if there was no significant 
change in the DO level. 
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Table 3.6 shown below was followed same for all the pharmaceuticals tested. Only the 
concentrations and volumes were changed for different samples. But the nutrient 
solution was added 8 mL for each step of test. 
Table 3.6. OUR measurement Table template 
 
S.N Measurement Nutrient Chemical Sludge 
1 Control (nutrient) 16 mg/L - - 
2 Chemical 5mg/L 16 mg/L 5mg/L - 
3 Chemical 10mg/L 16 mg/L 10mg/L - 
4 Chemical 15mg/L 16 mg/L 15mg/L - 
5 Sludge Control I 16 mg/L -     100 mL 
6 Sludge chemical 5mg/L 16 mg/L 5mg/L     100 mL 
7 Sludge chemical 10mg/L 16 mg/L 10mg/L     100 mL 
8 Sludge chemical 15mg/L 16 mg/L 15mg/L     100 mL 
9 Sludge Control II 16 mg/L -     100 mL 
 
 
The working volume of the chemicals depends upon the standard of the stock chemical. 
Working volumes were prepared according to the solubility of the chemicals.  
3.4.2. Mixed Liquor suspended solid (MLSS) Mixed Liquor Suspended Volatile 
Solid (MLVSS) method 
Apparatus needed: 
• Dry filters 
• Tweezers 
• Crucible 
• Weighing balance 
• Filtering device 
• Measuring cylinder 
• MilliQ-water 
• Hot Air Oven 
• Dessicator 
• Pipettes 
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Method 
The mixed liquor was collected from the test vessel after completing the measurement 
of DO. It was stored in each 500 mL BOD bottles and the lid was closed tightly. A dry 
filter paper was taken with tweezer and placed in a crucible and weighed. The filter was 
placed smooth down into the funnel of the filtering device. 
Sample was mixed vigorously and 10 mL of the mixed liquor was taken with a 
pipette in one stroke. It was poured over the filter paper slowly preventing the spoilage 
of the liquid out of the mouth of the filtering device. Sample was filtered and cylinder 
was rinsed with the MQ water. The filter was removed from the device and was placed 
in a crucible and dried in an oven preheated at 105˚C for 1 hour. The crucible was let 
cooled into a desiccator and weighed. MLSS was calculated as a difference between the 
initial mass and the current mass of the filter divided by the sample volume. This MLSS 
value was used later in determining OUR results 
The MLSS samples were put in another oven at 550°C for an hour. After the 
samples had cooled down their weight was measured and the weight loss due to burning 
(the difference the weight before the 550°C oven and after) was calculated and divided 
by the sample volume of 10 mL to obtain the MLVSS. Note: MLVSS values were not 
used in this experiment. 
Specific Oxygen Rate (SOUR) was obtained by dividing the OUR with MLSS 
values. This SOUR was used in calculating EC50 of the chemical. 
3.5. Screening of Active pharmaceuticals and selection of 
inhibitory compounds 
All above chemicals were screened for its inhibitory action by performing OUR test. 
Effective concentration 50 was calculated for each chemical to know the 50% inhibition 
of the activated sludge. The volume of above chemicals was different for some drugs 
because of their solubility difference. 
3.5.1 Calculation of OUR and MLSS 
 
The OUR method is already discussed above in the chapter 3.4.1. Calculation of OUR 
was done after taking the measurement. The temperature was maintained ±20 in all the 
tests. 
 
 
 50 
 
The oxygen uptake rate is defined by the following equation:  
 
OUR [mgO2/L/h] = dO2/dt                                                                                   (2) 
 
The SOUR is another parameter where the OUR is related to the mass of activated 
sludge:  
SOUR [mgO2/L/h/mgSS] = dO2/dt/MLSS                                              (3) 
 
In order to calculate the effect of chemicals the so called inhibition factor is used:  
 
                                                                (4) 
 
 
In equation (4), 
I =Inhibition 
RS = OUR of the sample  
RSC = OUR of the sample with chemical injection  
RC = OUR of water with chemical injection 
MLSS was calculated as 
Difference between the mass of the dry filter paper and mass of the filter paper after 
drying in 105˚C for 1 hour divided by the sample volume of 10 mL 
It can be expressed by equation (5) 
MLSS = 𝑀1−𝑀2
10𝑚𝐿
 g                                                    (5) 
Where, 
M1= 𝑀𝑎𝑠𝑠 𝑜𝑓 𝑡ℎ𝑒 𝐷𝑟𝑦 𝑓𝑖𝑙𝑡𝑒𝑟 𝑝𝑎𝑝𝑒𝑟 
M2= 𝑀𝑎𝑠𝑠 𝑜𝑓 𝑡ℎ𝑒 𝑓𝑖𝑙𝑡𝑒𝑟 𝑝𝑎𝑝𝑒𝑟 𝑎𝑓𝑡𝑒𝑟 𝑑𝑟𝑦𝑖𝑛𝑔 
g= 𝐺𝑟𝑎𝑚𝑠 
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For MLVSS calculation 
MLVSS= 𝑀2−𝑀3
10𝑚𝐿
 g 
Where, 
M2= 𝑀𝑎𝑠𝑠 𝑜𝑓 𝑡ℎ𝑒 𝑓𝑖𝑙𝑡𝑒𝑟 𝑝𝑎𝑝𝑒𝑟 𝑎𝑓𝑡𝑒𝑟 𝑑𝑟𝑦𝑖𝑛𝑔 𝑎𝑡 105˚C 
M3= 𝑀𝑎𝑠𝑠 𝑜𝑓 𝑡ℎ𝑒 𝑓𝑖𝑙𝑡𝑒𝑟 𝑝𝑎𝑝𝑒𝑟 𝑎𝑓𝑡𝑒𝑟 𝑑𝑟𝑦𝑖𝑛𝑔 at 550˚C 
g= 𝐺𝑟𝑎𝑚𝑠 
 
3.5.2 Calculation of EC50 concentration  
 
OUR calculation and EC50 concentration was calculated in the spreadsheet. At first the 
measurement datas of the time and the DO values were taken. Oxygen Consumption 
Rate by the chemical itself was decreased from OUR by chemical and sludge mixture 
(OUR-Chemical OUR). Then the SOUR was calculated by dividing the OUR value by 
MLSS value. Then the Inhibition percentage was calculated by the equation number 
4.Oxygen consumption curves for each measurement were drawn and oxygen uptake 
rate of each sample was obtained from a slope of each linear equation. After calculating 
inhibition percentage, EC50 was calculated by plotting the graph where Concentration of 
chemical is plotted against the inhibition %.  
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4. Results and Discussions 
4.1. Results of First Batch of chemicals 
Out of 22 chemicals tested in the first batch, 8 chemicals were found toxic to the 
activated sludge. The inhibition percentage and the EC50 values are interpreted below. 
Aspirin, Cetrimide, Chlorpheniramine Maleate, Caffeine anhydrous, Diclofenac sodium, 
Ephedrine Hcl, Levamisole Hcl, and Camphor showed the toxicity towards the activated 
sludge during OUR measurements. The OUR measurements with their EC50 
concentration are shown below in the pictures 
 
Aspirin 
 
 
 
 
 
 
 
 
 
Figure 4.1. Table with different concentrations of the Aspirin with their corresponding inhibition percentage 
calculating EC50 and the graph representing it. 
 
Results: 
   
                                                Concentration (mg/L)                              Inhibition % 
  20 17.5 
 
15 16.8 
 
10 11.7 
 
EC 50 50.5  mg/l 
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The concentration of the Aspirin was measured with the concentrations of 20 mg/L, 15 
mg/L and 10 mg/L.  The EC50 value was calculated as 50.5 mg/l. The time interval was 
10 minutes for each measurement. The MLSS values are shown for two sludge controls 
and three sludge mixed with different concentrations of the chemicals. The MLSS 
values for two sludge controls are nearly similar and the values for three other 
measurements are also nearly same. The stock Aspirin concentration was 1 g/L. 
Cetrimide 
Results: 
   
 
 
 
    Concentration(mg/L)                                   Inhibition % 
     20 58 
     15 22.7 
     10 33.2 
     EC 50 19.8 mg/l 
                          
 
 
 
 
The concentrations used for the measurement were 20 mg/L, 15mg/L and 10 mg/L.  
 
 
 
Figure 4.2. Table with different concentrations of the Cetrimide with their corresponding inhibition percentage 
calculating EC50 and the graph representing it. 
The inhibition was seen more with the concentration of 20 mg/L with inhibition 
percentage 58. The time interval was 10 minutes for each measurement. The stock 
Cetrimide concentration was 1 g/L. The MLSS values were nearly same for all the 
sludge parameters. The EC50 value obtained was 19.8 mg/l. 
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Chlorpheniramine Maleate 
Results: 
   
 
 
 
    Concentration (mg/L)   Inhibition % 
     20 7.6 
     15 59.2 
     10 -4.2 
     EC 50 36.4 mg/l 
     
       
 
      
       
       
 
 
 
 
 
 
 
Figure 4.3. Table with different concentrations of the Chlorpheniramine Maleate with their corresponding inhibition 
percentage calculating EC50 and the graph representing it. 
The stock concentration of Chlorpheniramine Maleate used for testing was 1 g/L. The 
three different concentrations of 20 mg/L, 15mg/L and 10 mg/L chemicals were tested. 
Concentration of 15 mg/L showed the highest effect with the inhibition of 59.6 %. The 
EC50 was calculated as 36.4 mg/l. 
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Caffeine Anhydrous 
   
 
 
 
    
 
Results: 
   
     
 
Concentration (mg/L) Inhibition % 
     
 
20 54.9 
     
 
15 58.6 
     
 
10 47 
     
 
EC 50 14.9  mg/l 
      
 
       
        
        
        
        
 
 
 
 
 
Figure 4.4. Table with different concentrations of the Caffeine Anhydrous with their corresponding inhibition 
percentage calculating EC50 and the graph representing it. 
The stock concentration of Caffeine Anhydrous used for testing was 1 g/L. The three 
different concentrations of 20 mg/L, 15mg/L and 10 mg/L chemicals were tested. 
Concentration of 15mg/L showed the highest effect with the inhibition of 58.6 %. The 
EC50 was calculated as 14.9 mg/l. With the concentration of 20 mg/l the inhibition was 
also nearly same as from 15 mg/L which was 54.9 mg/l. 
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Diclofenac Sodium 
 
 
Results: 
   
 
 
 
    
 
Concentration(mg/L)         Inhibition % 
     
 
20 39.1 
     
 
15 33.4 
     
 
10 24.8 
     
 
EC 50 23.7 mg/l 
     
        
 
       
        
        
        
 
 
 
 
 
 
Figure 4.4. Table with different concentrations of the Diclofenac Sodium with their corresponding inhibition 
percentage calculating EC50 and the graph representing it. 
The stock concentration of Diclofenac Sodium used for testing was 1 g/L. The three 
different concentrations of 20 mg/L, 15 mg/L and 10 mg/L chemicals were tested. 
Concentration of 20mg/L showed the highest effect with the inhibition of 39.1mg/l. The 
EC50 was calculated as 23.7 mg/l. With the concentration of 15 mg/L and 20 mg/L the 
inhibition was also nearly same with little lower inhibition was seen with 10 mg/L. 
 
 
 
 
 
y = 2,1117x
R² = 0,7457
0
10
20
30
40
50
60
0 5 10 15 20 25
In
hi
bi
tio
n 
pe
rc
en
ta
ge
 (%
)
Concentration (mg/l)
Inhibition
 57 
 
Ephedrine Hcl 
 
 
Results: 
   
 
 
 
    
 
Concentration(mg/L) Inhibition % 
     
 
20 33.2 
     
 
15 19.3 
     
 
10 15.5 
     
 
EC 50 32.7 mg/l 
     
 
       
        
        
        
 
 
 
 
 
 
Figure 4.5. Table with different concentrations of the Ephedrine Hcl with their corresponding inhibition percentage 
calculating EC50 and the graph representing it. 
The stock concentration of Ephedrine Hcl used for testing was 1 g/L. The three different 
concentrations of 20 mg/L, 15 mg/L and 10 mg/L chemicals were tested. Concentration 
of 20 mg/L showed the highest effect with the inhibition of 33.2%. The EC50 was 
calculated as 32.7 mg/l. With the concentration of 15 mg/L and 10 mg/L there was 
lower inhibition of 19.3 and 15.5% respectively. 
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 Levamisole Hcl 
 
 
Results: 
   
 
 
 
    
 
Concentration(mg/L) Inhibition % 
     
 
20 59.9 
     
 
15 44.5 
     
 
10 54.8 
     
 
EC 50 15 mg/l 
     
 
       
        
        
        
        
 
 
 
 
 
Figure 4.6. Table with different concentrations of the Levamisole Hcl with their corresponding inhibition percentage 
calculating EC50 and the graph representing it. 
The stock concentration of Levamisole Hcl used for testing was 1 g/L. The three 
different concentrations of 20 mg/L, 15 mg/L and 10 mg/L chemicals were tested. 
Concentration of 20mg/L showed the highest effect with the inhibition of 59.9%. The 
EC50 was calculated as 15 mg/l. With the concentration of 15 mg/L and 10 mg/L there 
was lower inhibition of 44.5 and 54.8 respectively. 
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Camphor 
 
Results: 
 
  
 
 
 
 
    
 
Concentration(mg/L) Inhibition % 
     
 
20 0 
     
 
15 26 
     
 
10 24.8 
     
 
EC 50 56.9 mg/l 
     
        
 
       
        
        
        
 
 
 
 
Figure 4.7. Table with different concentrations of the Camphor with their corresponding inhibition percentage 
calculating EC50 and the graph representing it. 
The stock concentration of Camphor used for testing was 1 g/L. The two different 
concentrations of 15mg/L and 10 mg/L chemicals were tested. Concentration of 15mg/L 
showed the highest effect with the inhibition of 26%. The EC50 was calculated as 56.9 
mg/l. With the concentration of 10 mg/L there was lower inhibition of 24.8 % which is 
closer to the inhibition of 15%. So there was no big difference between the inhibitions 
of two concentrations. 
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4.2. Results of Second Batch of chemicals 
Out of 10 chemicals tested in the second batch, three chemicals were found toxic to the 
activated sludge by using OUR method. The inhibition percentage and the EC50 values 
of the inhibitory ones are presented below 
Aminosidine  
 
Results: 
   
 
 
 
     
 
Concentration(mg/L) Inhibition % 
      
 
60 53.8 
      
 
40 45.9 
      
 
20 44.8 
      
 
EC 50 47 mg/l 
      
         
         
 
 
 
 
 
 
 
 
 
 
 
        
         
         
         
Figure 4.8. Table with different concentrations of the Aminosidine with their corresponding inhibition percentage 
calculating EC50 and the graph representing it. 
The stock concentration of Aminosidine used for testing was 1 g/L. The three different 
concentrations of 60mg/L, 40mg/L and 200 mg/L chemicals were tested. Concentration 
of 60mg/L showed the highest effect with the inhibition of 53.8%. The EC50 was 
calculated as 47 mg/l. With the concentration of 40 mg/L and 20mg/L there was  lower 
inhibition of 45.9 and 44.8 % respectively which are more closer to each other. So there 
was no big difference between the inhibitions of two concentrations. It can be seen as 
the three concentrations have decreasing inhibition with the decrease in concentrations. 
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Cetrizine 
          
 
Results: 
   
 
 
Concentration(mg/L)     Inhibition % 
 
5 20.1 
 
5 32 
 
2.5 10.8 
 
EC 50 9.8 mg/l 
   
 
  
   
   
   
   
         
 
 
 
 
Figure4.9.Table with different concentrations of the Cetrizine with their corresponding inhibition percentage 
calculating EC50 and the graph representing it 
The stock concentration of Cetrizine used for testing was 0.1 g/L. The three different 
concentrations of 5mg/L, 5mg/L and 2.5 mg/L chemicals were tested. Concentration of 
5mg/L showed the high effect with the inhibition of 20.1%. Again the same 
concentration was used which showed the highest inhibition of 32%. The EC50 was 
calculated as 9.8 mg/l. With the concentration of 2.5mg/L it showed the effect of 10.8 
which was nearly half inhibition than that the concentration with 5mg/L. So the result 
seems reasonable. 
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Quinine Dihydrochloride  
 
 
Results: 
   
 
 
 
     
 
              Concentration(mg/L)     Inhibition % 
      
 
5 36.3 
      
 
5 39 
      
 
2.5 35.9 
      
 
                                        EC 50                     6 mg/l 
      
         
 
        
         
         
         
         
         
 
 
 
 
 
Figure 4.10. Table with different concentrations of the Quinine Dihydrochloride with their corresponding inhibition 
percentage calculating EC50 and the graph representing it. 
The stock concentration of Quinine Dihydrochloride used for testing was 0.1 g/L. The 
three different concentrations of 5mg/L, 5mg/L and 2.5 mg/L chemicals were tested. 
Concentration of 5mg/L showed the high effect with the inhibition of 36.3% and again 
the same concentration showed 39% of inhibition. 2.5 mg/L concentration showed 
35.9% of inhibition. So the result showed quite same inhibition percentage with all three 
concentrations. The EC50 was calculated as 6 mg/l. 
With third and fourth batch of chemicals no significant toxicity was seen with OUR 
measurements. But few more pharmaceutical results are presented below which were 
non toxic to the activated sludge. 
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Amodiaquine Hcl 
 
Results 
   
                         Concentration                 Inhibition % 
60 20.3 
40 29 
20 17.3 
EC 50 102.9 mg/l 
 
 
Figure 4.11. Table with different concentrations of the Amodiaquine Hcl with their corresponding inhibition 
percentage calculating EC50 and the graph representing it. 
 
The stock concentration of Amodiaquine Hcl used for testing was 1 g/L. The three 
different concentrations of 60 mg/L, 40 mg/L and 20 mg/L chemicals were tested. 
Concentration of 40mg/L showed the high effect with the inhibition of 29% and 60 
mg/L concentration showed 20.3% of inhibition. 20 mg/L concentration showed 17.3% 
of inhibition. So the result showed quite same inhibition percentage with all three 
concentrations. The EC50 was calculated as 102.9 mg/l. 
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Folic Acid 
 
 Results 
   
                     Concentration               Inhibition % 
20 18.9 
15 -19.3 
10 15.4 
EC 50 149 mg/l 
 
 
Figure 4.12. Table with different concentrations of the Folic Acid with their corresponding inhibition percentage 
calculating EC50 and the graph representing it. 
 
The stock concentration of Folic acid used for testing was 1 g/L. The three different 
concentrations of 20 mg/L, 15 mg/L and 10 mg/L chemicals were tested. Concentration 
of 20 mg/L showed the high effect with the inhibition of 18.9% and 10 mg/L 
concentration showed 15.4% of inhibition. 15 mg/L concentration showed -19.3% of 
inhibition. So the result didn’t show same inhibition percentage with all three 
concentrations. The EC50 was calculated as 149 mg/l. 
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Thiamine Hcl 
 
Results 
   
                       Concentration                Inhibition % 
300 41.6 
200 50.9 
100 -16.8 
EC 50 333.8 mg/l 
 
 
Figure 4.13. Table with different concentrations of the Thiamine Hcl with their corresponding inhibition percentage 
calculating EC50 and the graph representing it. 
The stock concentration of Thiamine Hcl used for testing was 1 g/L. The three different 
concentrations of 300mg/L, 200mg/L and 100 mg/L chemicals were tested. 
Concentration of 200mg/L showed the high effect with the inhibition of 50.9% and 300 
mg/L concentration showed 41.6% of inhibition. 100 mg/L concentration showed -16.8 
% of inhibition. So the result didn’t show same inhibition percentage with all three 
concentrations. The EC50 was calculated as 333.8 mg/l. 
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5. Conclusions 
Different types of pharmaceuticals are manufactured in the pharmaceutical company. It 
is very important to do screening for these pharmaceuticals inorder to maintain the good 
efficiency of waste water treatment plant. There are different ways of wastewater 
treatment. Among them, Biological wastewater treatment has been followed inorder to 
remove this pharmaceuticals. Inorder to know the efficiency level of the biological 
treatment plant, the toxicity of these chemicals should be known.  
Activated sludge is the main component of this kind of treatment plant. The sludge 
contains various microorganisms which consume oxygen for the respiration. When 
those toxic chemicals are mixed with the sludge, it decreases the oxygen consumption 
capacity of the microorganisms proving that the specific pharmaceutical is harmful for 
the biological wastewater treatment plant. This is the basic principle behind the toxicity 
measurement of these pharmaceuticals. The measurement technique followed was the 
OUR (Oxygen Uptake Rate) method. 50 Pharmaceuticals were tested with OUR method 
for its toxicity towards the activated sludge and 11 compounds found to be toxic with 
50% inhibition at different concentrations. Drugs were tested with varying 
concentrations inorder to check the maximum concentration causing the toxicity. OUR 
was calculated as slope, SOUR was calculated by dividing OUR by MLSS values. 
Effective Concentration 50 (EC50) for Diclofenac is 11.5-22.7 mg/L and the observed 
EC50 in this work was 23.7 mg/L. Diclofenac Sodium was found to be toxic. It is a 
poor biodegradable chemical. Likewise, Aspirin, Cetrimide, Cetrizine, 
Chlorpheniramine Maleate, Caffeine Anhydrous, Ephedrine Hcl, Levamisole Hcl, 
Quinine Dihydrochloride and Camphor were found toxic. These eight pharmaceuticals 
showed the significant inhibition of the oxygen consumption of the activated sludge 
tested in the laboratory. In the practical part of this work, inhibitions were calculated 
and graphs were plotted with concentrations vs inhibition percentage inorder to 
calculate the EC50 values. 
Pharmaceuticals not only inhibit the oxygen consumption but also it acts as a food 
sometimes. When there are clumps in the sludge, the oxygen consumption rate may be 
affected because the bulky portions in the sludge won’t consume oxygen. Therefore the 
sludge should be homogenous. The main aim of this work was to find the toxic 
chemicals to the biological wastewater treatment plant in the pharmaceutical industry. 
Since the new drugs are being manufactured continuously, these drugs should be 
screened before they come in contact with the biological treatment system.  
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